Related Experiment Video
Updated: Jan 7, 2026

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
Cannabidiol Enhances SIRT1 and Autophagy for the Maintenance of Human Mesenchymal Stem Cells
Phongsakorn Chueaphromsri1, Phongsakorn Kunhorm1, Areechun Sotthibundhu2
1Laboratory of Cell-Based Assays and Innovations, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima, Thailand.
Background/Aim:
Mesenchymal stem cells (MSCs) are used to treat various degenerative diseases. However, their therapeutic potential is limited by cellular aging during in vitro cultivation. This study aimed to explore whether cannabidiol (CBD) can delay MSC aging by enhancing the expression of Sirtuin 1 (SIRT1) and autophagy, two key anti-aging regulators.
Materials And Methods:
CBD, the most important non-psychotomimetic phytocannabinoid derived from the Cannabis sativa plant, was used to up-regulate SIRT1 and autophagy in order to maintain MSC stemness. MSCs were treated with CBD and assessed for cell viability, doubling time, key gene/protein expression, relative senescence-associated β-galactosidase (SA-β-gal) assay, relative telomere length, and telomerase expression.
Results:
CBD significantly increased the expression of SIRT1 and autophagy-related markers in MSCs. Furthermore, CBD preserved MSC stemness by promoting the deacetylation of SRY-box transcription factor 2 (SOX2) through SIRT1, and delayed cellular senescence by enhancing autophagy, reducing SA-β-gal activity, maintaining proliferation capacity, and supporting telomere function.
Conclusion:
CBD promotes MSC stemness and delays cellular senescence, potentially through the activation of SIRT1 and autophagy. These findings suggest that CBD may serve as a promising agent for preserving MSC function in regenerative medicine.
Insights
Cannabidiol (CBD) delays aging in mesenchymal stem cells (MSCs) by boosting Sirtuin 1 (SIRT1) and autophagy. This preserves MSC stemness and function, offering potential for regenerative medicine applications.
Area of Science:
- Stem cell biology
- Molecular gerontology
- Pharmacology
Background:
- Mesenchymal stem cells (MSCs) are crucial for treating degenerative diseases.
- Cellular aging limits MSC therapeutic efficacy during in vitro cultivation.
- Identifying strategies to maintain MSC stemness and delay senescence is vital.
Purpose of the Study:
- To investigate if cannabidiol (CBD) can delay MSC aging.
- To explore CBD's effect on Sirtuin 1 (SIRT1) and autophagy.
- To assess CBD's potential to preserve MSC stemness and function.
Main Methods:
- MSCs were treated with CBD.
- Assessed cell viability, doubling time, and key gene/protein expression.
- Evaluated senescence markers (SA-β-gal), telomere length, and telomerase activity.
Main Results:
- CBD significantly upregulated SIRT1 and autophagy markers in MSCs.
- CBD preserved MSC stemness by promoting SOX2 deacetylation via SIRT1.
- CBD delayed senescence, reduced SA-β-gal activity, and maintained proliferation and telomere function.
Conclusions:
- CBD promotes MSC stemness and delays cellular senescence.
- CBD's effects are potentially mediated by activating SIRT1 and autophagy.
- CBD shows promise for preserving MSC function in regenerative medicine.
More Related Videos
Related Concept Videos
Mesenchymal Stem Cells
Multipotency of Hematopoietic Stem Cells

